一般財団法人化学及血清療法研究所が製造販売するインフルエンザHAワクチンについて｜厚生労働省
https://www.mhlw.go.jp/stf/houdou/0000101868.htmlThe evidence pack includes HTML, screenshots, summaries, and metadata. It can be downloaded on Pro.
External timestamp
The evidence pack includes the third-party timestamp files.
一般財団法人化学及血清療法研究所が製造販売するインフルエンザHAワクチンについて｜厚生労働省
Open the archived HTML with saved-time metadata attached.
This HTML has CSS and images embedded, so it can still be opened even if the original page disappears.
This page announces the Ministry of Health, Labour and Welfare's decision regarding influenza HA vaccine manufactured by the Chemical and Serum Therapy Research Institute. The ministry had requested suspension of shipments in September due to discrepancies between approval documentation and manufacturing practices. Following detailed review, no significant impact on product quality and safety was identified. The Infectious Disease Division of the Health Science Council concluded that shipment should be permitted to prevent influenza transmission and avoid supply shortages. Consequently, the ministry lifted the shipment suspension order on the announced date.
